Every Monday we attend an informal meeting with NTU’s School of Pharmacy’s graduate students and faculy. The graduate program is an additional 2 years of education after students obtain their bachelors in pharmacy (which is a 4 year program after high school). The informal meeting is somewhat similar to the therapeutics conferences that we have at UCSF. Every week, two students will do a case presentation and focus on a part of the patient’s therapy that they found interesting or had a specific question about. After presenting their findings to their classmates and the faculty , if any additional questions are brought up, the student will research again for the following week.
On occasion, these informal meetings will have guest lecturers. This past week our guest speaker was Dr. Daniel Mullins, who is a pharmacoeconomics professor at the University of Maryland’s School of Pharmacy. His presentation was on “Comparative Effectiveness Research for Health Intervention Assessments Improving Health.” Comparative effectiveness research (CER) refers to the process of evaluating the impact of different options for treating a given medical condition for a particular set of patients. The goal of this idea isn’t to find out what the best drug is, but rather what the best drug for this patient is. Instead of being investigator driven, CER is demand driven, meaning that it is defined by the needs of the decision makers (public and private payers, clinicians, patients, and professionals). It utilizes the PICOT method to establish a clinical research question.
P (the type of People represented)
I (intervention)
C (Comparative intervention)
O (outcome of interest)
T (Timeframe)
Overall it was an informative presentation on a topic that we have not had exposure to at UCSF.
No comments:
Post a Comment